HEADER HYDROLASE 08-JUN-22 8A3Q TITLE HUMAN PLASMA KALLEKREIN IN COMPLEX WITH 14W COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMA KALLIKREIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: FLETCHER FACTOR,KININOGENIN,PLASMA PREKALLIKREIN,PKK; COMPND 5 EC: 3.4.21.34; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLKB1, KLK3; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: X33; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS INHIBITOR, COMPLEX, SERINE-LIKE PROTEASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR P.A.MCEWAN REVDAT 3 31-JAN-24 8A3Q 1 REMARK REVDAT 2 09-NOV-22 8A3Q 1 JRNL REVDAT 1 02-NOV-22 8A3Q 0 JRNL AUTH R.L.DAVIE,H.J.EDWARDS,D.M.EVANS,S.T.HODGSON,M.J.STOCKS, JRNL AUTH 2 A.J.SMITH,L.J.RUSHBROOKE,S.J.PETHEN,M.B.ROE,D.E.CLARK, JRNL AUTH 3 P.A.MCEWAN,S.L.HAMPTON JRNL TITL SEBETRALSTAT (KVD900): A POTENT AND SELECTIVE SMALL MOLECULE JRNL TITL 2 PLASMA KALLIKREIN INHIBITOR FEATURING A NOVEL P1 GROUP AS A JRNL TITL 3 POTENTIAL ORAL ON-DEMAND TREATMENT FOR HEREDITARY JRNL TITL 4 ANGIOEDEMA. JRNL REF J.MED.CHEM. V. 65 13629 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36251573 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00921 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.8 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 66.0 REMARK 3 NUMBER OF REFLECTIONS : 15758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 786 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.92 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 10.17 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3085 REMARK 3 BIN FREE R VALUE : 0.3124 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 15 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1904 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 64 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.32020 REMARK 3 B22 (A**2) : -1.77940 REMARK 3 B33 (A**2) : 7.09960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.255 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.202 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.251 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.202 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2027 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2754 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 697 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 348 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2027 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 256 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1618 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.46 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|16 - A|248 } REMARK 3 ORIGIN FOR THE GROUP (A): 15.8537 14.2141 10.7599 REMARK 3 T TENSOR REMARK 3 T11: -0.087 T22: -0.0122 REMARK 3 T33: 0.0868 T12: 0.0696 REMARK 3 T13: 0.0783 T23: 0.1208 REMARK 3 L TENSOR REMARK 3 L11: 6.3147 L22: 1.7913 REMARK 3 L33: 1.0705 L12: -2.1269 REMARK 3 L13: -0.4183 L23: 0.916 REMARK 3 S TENSOR REMARK 3 S11: -0.5368 S12: 0.0038 S13: 0.1127 REMARK 3 S21: 0.0038 S22: 0.3111 S23: -0.0759 REMARK 3 S31: 0.1127 S32: -0.0759 S33: 0.2257 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A3Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123327. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 TO 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978563 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS FEB 5, 2021 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4, STARANISO 2.3.77 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15758 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.801 REMARK 200 RESOLUTION RANGE LOW (A) : 49.875 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 200 DATA REDUNDANCY : 6.280 REMARK 200 R MERGE (I) : 0.05860 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.0800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 5.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 49.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 5.76 REMARK 200 R MERGE FOR SHELL (I) : 0.04650 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 32.39 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ANW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 6K, 0.10 M MES, PH 6.5, 14 REMARK 280 MG/ML PROTEIN INCLUDING 20 MM BENZAMIDINE. 1:1 RATIO OF PROTEIN REMARK 280 TO MOTHER LIQUOR AT 1 + 1 MICROLITERS OVER A 500 MICROLITER REMARK 280 RESERVOIR AT 18 CELSIUS, PH 5.5, COUNTER-DIFFUSION, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 31.71900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.50900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.71900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.50900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 1 REMARK 465 THR A 2 REMARK 465 GLY A 3 REMARK 465 ASP A 4 REMARK 465 ASN A 5 REMARK 465 SER A 6 REMARK 465 VAL A 7 REMARK 465 SER A 8 REMARK 465 THR A 9 REMARK 465 THR A 10 REMARK 465 LYS A 11 REMARK 465 THR A 12 REMARK 465 SER A 13 REMARK 465 THR A 14 REMARK 465 ARG A 15 REMARK 465 ALA A 249 REMARK 465 GLN A 250 REMARK 465 MET A 251 REMARK 465 GLN A 252 REMARK 465 SER A 253 REMARK 465 PRO A 254 REMARK 465 ALA A 255 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 37 -110.21 -105.99 REMARK 500 ASP A 65B -42.41 58.98 REMARK 500 ASN A 135 76.81 -117.56 REMARK 500 SER A 214 -65.60 -120.44 REMARK 500 ALA A 221 16.83 59.13 REMARK 500 SER A 244 -14.34 -46.96 REMARK 500 SER A 245 -41.12 77.25 REMARK 500 REMARK 500 REMARK: NULL DBREF 8A3Q A 1 255 UNP P03952 KLKB1_HUMAN 376 638 SEQADV 8A3Q SER A 8 UNP P03952 CYS 383 ENGINEERED MUTATION SEQADV 8A3Q SER A 122 UNP P03952 CYS 503 ENGINEERED MUTATION SEQRES 1 A 263 ASN THR GLY ASP ASN SER VAL SER THR THR LYS THR SER SEQRES 2 A 263 THR ARG ILE VAL GLY GLY THR ASN SER SER TRP GLY GLU SEQRES 3 A 263 TRP PRO TRP GLN VAL SER LEU GLN VAL LYS LEU THR ALA SEQRES 4 A 263 GLN ARG HIS LEU CYS GLY GLY SER LEU ILE GLY HIS GLN SEQRES 5 A 263 TRP VAL LEU THR ALA ALA HIS CYS PHE ASP GLY LEU PRO SEQRES 6 A 263 LEU GLN ASP VAL TRP ARG ILE TYR SER GLY ILE LEU ASN SEQRES 7 A 263 LEU SER ASP ILE THR LYS ASP THR PRO PHE SER GLN ILE SEQRES 8 A 263 LYS GLU ILE ILE ILE HIS GLN ASN TYR LYS VAL SER GLU SEQRES 9 A 263 GLY ASN HIS ASP ILE ALA LEU ILE LYS LEU GLN ALA PRO SEQRES 10 A 263 LEU ASN TYR THR GLU PHE GLN LYS PRO ILE SER LEU PRO SEQRES 11 A 263 SER LYS GLY ASP THR SER THR ILE TYR THR ASN CYS TRP SEQRES 12 A 263 VAL THR GLY TRP GLY PHE SER LYS GLU LYS GLY GLU ILE SEQRES 13 A 263 GLN ASN ILE LEU GLN LYS VAL ASN ILE PRO LEU VAL THR SEQRES 14 A 263 ASN GLU GLU CYS GLN LYS ARG TYR GLN ASP TYR LYS ILE SEQRES 15 A 263 THR GLN ARG MET VAL CYS ALA GLY TYR LYS GLU GLY GLY SEQRES 16 A 263 LYS ASP ALA CYS LYS GLY ASP SER GLY GLY PRO LEU VAL SEQRES 17 A 263 CYS LYS HIS ASN GLY MET TRP ARG LEU VAL GLY ILE THR SEQRES 18 A 263 SER TRP GLY GLU GLY CYS ALA ARG ARG GLU GLN PRO GLY SEQRES 19 A 263 VAL TYR THR LYS VAL ALA GLU TYR MET ASP TRP ILE LEU SEQRES 20 A 263 GLU LYS THR GLN SER SER ASP GLY LYS ALA GLN MET GLN SEQRES 21 A 263 SER PRO ALA HET UNL A 301 36 HET MES A 302 12 HET NAG A 303 14 HETNAM UNL UNKNOWN LIGAND HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 MES C6 H13 N O4 S FORMUL 4 NAG C8 H15 N O6 FORMUL 5 HOH *64(H2 O) HELIX 1 AA1 ALA A 55 ASP A 60 5 6 HELIX 2 AA2 ASN A 72 ILE A 76 5 5 HELIX 3 AA3 SER A 125 THR A 131 5 7 HELIX 4 AA4 THR A 164 TYR A 172 1 9 HELIX 5 AA5 TYR A 234 GLN A 243 1 10 SHEET 1 AA1 8 THR A 20 ASN A 21 0 SHEET 2 AA1 8 GLN A 156 ASN A 159 -1 O LYS A 157 N THR A 20 SHEET 3 AA1 8 ASN A 135 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 4 AA1 8 PRO A 198 HIS A 203 -1 O VAL A 200 N TRP A 137 SHEET 5 AA1 8 MET A 208B TRP A 215 -1 O MET A 208B N HIS A 203 SHEET 6 AA1 8 GLY A 226 LYS A 230 -1 O VAL A 227 N TRP A 215 SHEET 7 AA1 8 MET A 180 ALA A 183 -1 N VAL A 181 O TYR A 228 SHEET 8 AA1 8 LEU A 162 VAL A 163 -1 N VAL A 163 O CYS A 182 SHEET 1 AA2 6 TRP A 65D SER A 68 0 SHEET 2 AA2 6 GLN A 30 LYS A 36 -1 N GLN A 34 O ARG A 65E SHEET 3 AA2 6 GLN A 38B LEU A 46 -1 O CYS A 42 N LEU A 33 SHEET 4 AA2 6 TRP A 51 THR A 54 -1 O LEU A 53 N SER A 45 SHEET 5 AA2 6 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 6 AA2 6 ILE A 85 ILE A 90 -1 N LYS A 86 O LYS A 107 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.06 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.04 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.04 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.03 LINK ND2 ASN A 21 C1 NAG A 303 1555 1555 1.43 CRYST1 63.438 79.018 49.875 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015763 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012655 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020050 0.00000